Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial

PURPOSE: The adoption of hypofractionated whole-breast irradiation (HF-WBI) remains low, in part because of concerns regarding its safety when used with a tumor bed boost or in patients who have received chemotherapy or have large breast size. To address this, we conducted a randomized, multicenter...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Oncol
Autori principali: Shaitelman, Simona F., Lei, Xiudong, Thompson, Alastair, Schlembach, Pamela, Bloom, Elizabeth S., Arzu, Isidora Y., Buchholz, Daniel, Chronowski, Gregory, Dvorak, Tomas, Grade, Emily, Hoffman, Karen, Perkins, George, Reed, Valerie K., Shah, Shalin J., Stauder, Michael C., Strom, Eric A., Tereffe, Welela, Woodward, Wendy A., Amaya, Diana N., Shen, Yu, Hortobagyi, Gabriel N., Hunt, Kelly K., Buchholz, Thomas A., Smith, Benjamin D.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2018
Soggetti:
ORIGINAL REPORTS
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6286164/
https://ncbi.nlm.nih.gov/pubmed/30379626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.00317
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi